Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects
Status:
Completed
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
A randomized, open label, single dose, balanced, two treatment, two sequence, four period,
fully replicate, cross over bioequivalence study under fasting condition.